Literature DB >> 22526810

Benefit of Monascus-fermented products for hypertension prevention: a review.

Bao-Hong Lee1, Tzu-Ming Pan.   

Abstract

γ-Aminobutyric acid (GABA) has been reported to play a neurotransmitter in the central nervous system thereby exerting an inhibition in nerve impulse, in turn ameliorating depression; in addition, recent study also reveals the anti-hypertensive effect of GABA in vivo. Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including anti-inflammatory pigments (such as monascin and ankaflavin), monacolins, dimerumic acid, and GABA. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, anti-oxidative, and anti-tumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer in recent studies. The current article discusses and provides evidence to elucidate the anti-hypertensive benefit of Monascus-fermented metabolites, including anti-inflammatory pigments and GABA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526810     DOI: 10.1007/s00253-012-4076-2

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  Cloning and functional analysis of the Gβ gene Mgb1 and the Gγ gene Mgg1 in Monascus ruber.

Authors:  Li Li; Lu He; Yong Lai; Yanchun Shao; Fusheng Chen
Journal:  J Microbiol       Date:  2014-01-04       Impact factor: 3.422

2.  Phylogenetic analysis of Monascus and new species from honey, pollen and nests of stingless bees.

Authors:  R N Barbosa; S L Leong; O Vinnere-Pettersson; A J Chen; C M Souza-Motta; J C Frisvad; R A Samson; N T Oliveira; J Houbraken
Journal:  Stud Mycol       Date:  2017-04-12       Impact factor: 16.097

Review 3.  Production of valuable compounds by molds and yeasts.

Authors:  Arnold L Demain; Evan Martens
Journal:  J Antibiot (Tokyo)       Date:  2016-10-12       Impact factor: 2.649

4.  Genetic Modification of mfsT Gene Stimulating the Putative Penicillin Production in Monascus ruber M7 and Exhibiting the Sensitivity towards Precursor Amino Acids of Penicillin Pathway.

Authors:  Rabia Ramzan; Muhammad Safiullah Virk; Zafarullah Muhammad; Amani Mohedein Mohammed Ahmed; Xi Yuan; Fusheng Chen
Journal:  Microorganisms       Date:  2019-09-24

5.  Monascus sanguineus May Be a Natural Nothospecies.

Authors:  Yatao He; Junlin Liu; Qian Chen; Senning Gan; Ting Sun; Shengdong Huo
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

6.  Comparative transcriptomic analysis reveals the regulatory effects of inorganic nitrogen on the biosynthesis of Monascus pigments and citrinin.

Authors:  Jia-Li Hong; Li Wu; Jin-Qiang Lu; Wen-Bin Zhou; Ying-Jia Cao; Wen-Long Lv; Bin Liu; Ping-Fan Rao; Li Ni; Xu-Cong Lv
Journal:  RSC Adv       Date:  2020-02-03       Impact factor: 4.036

7.  The ABCT31 Transporter Regulates the Export System of Phenylacetic Acid as a Side-Chain Precursor of Penicillin G in Monascus ruber M7.

Authors:  Rabia Ramzan; Muhammad Safiullah Virk; Fusheng Chen
Journal:  Front Microbiol       Date:  2022-07-28       Impact factor: 6.064

8.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

9.  An Integrated Approach to Determine the Boundaries of the Azaphilone Pigment Biosynthetic Gene Cluster of Monascus ruber M7 Grown on Potato Dextrose Agar.

Authors:  Qingpei Liu; Siyu Zhong; Xinrui Wang; Shuaibiao Gao; Xiaolong Yang; Fusheng Chen; István Molnár
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.